Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Filamon LTD
Fred Hutchinson Cancer Center
Mayo Clinic
University of California, Davis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ViroMissile, Inc.
Replimune Inc.
University of Florida
Pfizer
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
Essen Biotech
OHSU Knight Cancer Institute
Novartis
Daiichi Sankyo
M.D. Anderson Cancer Center
Second Life Therapeutics
NRG Oncology
M.D. Anderson Cancer Center
AgonOx, Inc.
Novartis
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University Health Network, Toronto
Petrov, Andrey
AstraZeneca
Revolution Medicines, Inc.
Tempus AI
Virginia Commonwealth University
British Columbia Cancer Agency
Guangzhou FineImmune Biotechnology Co., LTD.
Obsidian Therapeutics, Inc.
Washington University School of Medicine
Institut Cancerologie de l'Ouest
Incyte Corporation
Milton S. Hershey Medical Center
Marengo Therapeutics, Inc.
NRG Oncology
Thomas Jefferson University
Columbia University
University of Arizona
Revolution Medicines, Inc.
Novartis
Stanford University
The University of Hong Kong-Shenzhen Hospital
Cedars-Sinai Medical Center